Brought to you by the publisher of Life Sciences Intellectual Property Review, the 2017 event series will bring together an unrivalled audience of intellectual property and licensing heads from established and fledgling pharma and biotech companies, along with private practice attorneys, and service providers. This conference provides delegates with an invaluable opportunity to gain insight into the sector issues of critical current importance; listen to best-in-class case studies; keep abreast of the likely forward impact of key judgements and political jolts; and network with global patent peers.